These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6936607)

  • 1. Acute promyelocytic leukemia in children.
    Chan KW; Steinherz PG; Miller DR
    Med Pediatr Oncol; 1981; 9(1):5-15. PubMed ID: 6936607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute promyelocytic leukemia.
    Kingsley EC; Durie BG; Garewal HS
    West J Med; 1987 Mar; 146(3):322-7. PubMed ID: 3472414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute promyelocytic leukemia is a distinct subset of acute myelocytic leukemia with unique clinicopathologic characteristics including longer duration of relapse free survival: experience in 13 cases.
    Lee KH; Kim DH; Lee JS; Suh CW; Kim SW; Kim SB; Lee JH; Doh BS; Chi HS; Lee MS
    J Korean Med Sci; 1994 Dec; 9(6):437-43. PubMed ID: 7786438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute promyelocytic leukemia presenting as a pelvic mass.
    Belasco JB; Bryan JH; McMillan CW
    Med Pediatr Oncol; 1978; 4(4):289-95. PubMed ID: 281594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute promyelocytic leukemia--clinical management of 15 patients.
    Daly PA; Schiffer CA; Wiernik PH
    Am J Hematol; 1980; 8(4):347-59. PubMed ID: 6932177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of acute promyelocytic leukemias in children].
    Fernández MJ; Javier G; Tusell J; Ortega JJ
    An Esp Pediatr; 1984 Jun; 20(9):869-75. PubMed ID: 6592998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical characteristics and treatment results of acute promyelocytic leukemia in children (Children's Cancer and Leukemia Study Group)].
    Shimizu H; Nakadate H; Taga T; Utsumi J; Nishikawa K; Gushiken T; Horikoshi Y; Oka T; Kikuta A; Maeda H
    Rinsho Ketsueki; 1993 Sep; 34(9):989-96. PubMed ID: 8230751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute promyelocytic leukemia. Management of the coagulopathy during daunorubicin-prednisone remission induction.
    Collins AJ; Bloomfield CD; Peterson BA; McKenna RW; Edson JR
    Arch Intern Med; 1978 Nov; 138(11):1677-80. PubMed ID: 281191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complete remission in acute promyelocytic leukemia despite persistence of abnormal bone marrow promyelocytes during induction therapy: experience in 34 patients.
    Stone RM; Maguire M; Goldberg MA; Antin JH; Rosenthal DS; Mayer RJ
    Blood; 1988 Mar; 71(3):690-6. PubMed ID: 3422828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Childhood acute promyelocytic leukemia: no benefit of all-trans-retinoic acid administered in a short-course schedule.
    Zubizarreta PA; Rose AB; Felice MS; Alfaro E; Delfino S; Cygler AM; Sackmann-Muriel F
    Pediatr Hematol Oncol; 2000 Mar; 17(2):155-62. PubMed ID: 10734658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute promyelocytic leukemia: impact of hemorrhagic complications on response to induction chemotherapy and survival.
    Humphries JE; Hess CE; Stewart FM
    South Med J; 1990 Oct; 83(10):1157-61. PubMed ID: 2218655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beneficial effect of heparin in the management of patients with APL.
    Hoyle CF; Swirsky DM; Freedman L; Hayhoe FG
    Br J Haematol; 1988 Mar; 68(3):283-9. PubMed ID: 3162683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prophylactic heparin therapy in acute promyelocytic leukemia.
    Drapkin RL; Gee TS; Dowling MD; Arlin Z; McKenzie S; Kempin S; Clarkson B
    Cancer; 1978 Jun; 41(6):2484-90. PubMed ID: 274995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors in acute promyelocytic leukemia: strategies to define high-risk patients.
    Testa U; Lo-Coco F
    Ann Hematol; 2016 Apr; 95(5):673-80. PubMed ID: 26920716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparin treatment for the hemorrhagic diathesis of acute promyelocytic leukemia.
    Gralnick HR; Bagley J; Abrell E
    Am J Med; 1972 Feb; 52(2):167-74. PubMed ID: 4500954
    [No Abstract]   [Full Text] [Related]  

  • 16. Analysis of factors affecting hemorrhagic diathesis and overall survival in patients with acute promyelocytic leukemia.
    Lee HJ; Kim DH; Lee S; Koh MS; Kim SY; Lee JH; Lee S; Oh SY; Han JY; Kim HJ; Kim SH
    Korean J Intern Med; 2015 Nov; 30(6):884-90. PubMed ID: 26552464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Daunomycin monotherapy in acute promyelocytic leukemia].
    Gmür J; Gürtler J; Straub PW
    Schweiz Med Wochenschr; 1976 Feb; 106(7):205-9. PubMed ID: 1061997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. THP-ADM in the treatment of acute promyelocytic leukemia.
    Uzuka Y; Saito Y
    Tohoku J Exp Med; 1985 May; 146(1):1-8. PubMed ID: 3861002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute promyelocytic leukemia: a model for understanding the role of the malignant cell in hemostasis.
    Gralnick HR; Tan HK
    Hum Pathol; 1974 Nov; 5(6):661-73. PubMed ID: 4607877
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of all-trans retinoic acid on the newly diagnosed acute promyelocytic leukaemia: our experience].
    Rolovitsh Z; Cholovitsh M; Elezovitsh I; Vidovitsh A; Radoshevitsh-Radojkovitsh N; Boshkovitsh D; Novak A; Basara N
    Srp Arh Celok Lek; 1995; 123(11-12):279-85. PubMed ID: 16296239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.